These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17887772)

  • 1. Very large scale monoclonal antibody purification: the case for conventional unit operations.
    Kelley B
    Biotechnol Prog; 2007; 23(5):995-1008. PubMed ID: 17887772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process and economic evaluation for monoclonal antibody purification using a membrane-only process.
    Varadaraju H; Schneiderman S; Zhang L; Fong H; Menkhaus TJ
    Biotechnol Prog; 2011; 27(5):1297-305. PubMed ID: 21618725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to chromatographic separations.
    Thömmes J; Etzel M
    Biotechnol Prog; 2007; 23(1):42-5. PubMed ID: 17269668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioseparation in antibody manufacturing: the good, the bad and the ugly.
    Gottschalk U
    Biotechnol Prog; 2008; 24(3):496-503. PubMed ID: 18442255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic concepts in Q membrane chromatography for large-scale antibody production.
    Zhou JX; Tressel T
    Biotechnol Prog; 2006; 22(2):341-9. PubMed ID: 16599545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process economics of industrial monoclonal antibody manufacture.
    Farid SS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):8-18. PubMed ID: 16899415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production.
    Dizon-Maspat J; Bourret J; D'Agostini A; Li F
    Biotechnol Bioeng; 2012 Apr; 109(4):962-70. PubMed ID: 22094920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of purification operations in biotechnology: enabling process development, optimization, and scale-up.
    Velayudhan A; Menon MK
    Biotechnol Prog; 2007; 23(1):68-73. PubMed ID: 17269673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation.
    Hammerschmidt N; Tscheliessnig A; Sommer R; Helk B; Jungbauer A
    Biotechnol J; 2014 Jun; 9(6):766-75. PubMed ID: 24706569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in large-scale production of monoclonal antibodies and related proteins.
    Shukla AA; Thömmes J
    Trends Biotechnol; 2010 May; 28(5):253-61. PubMed ID: 20304511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane adsorbers as purification tools for monoclonal antibody purification.
    Boi C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):19-27. PubMed ID: 16996324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line.
    Kuczewski M; Schirmer E; Lain B; Zarbis-Papastoitsis G
    Biotechnol J; 2011 Jan; 6(1):56-65. PubMed ID: 21170980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in primary recovery: centrifugation and membrane technology.
    Roush DJ; Lu Y
    Biotechnol Prog; 2008; 24(3):488-95. PubMed ID: 18410157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly efficient integrated chromatographic procedure for the purification of recombinant hepatitis B surface antigen from Hansenula polymorpha.
    Huang Y; Bi J; Zhang Y; Zhou W; Li Y; Zhao L; Su Z
    Protein Expr Purif; 2007 Dec; 56(2):301-10. PubMed ID: 17910922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-based techniques for the separation and purification of proteins: an overview.
    Saxena A; Tripathi BP; Kumar M; Shahi VK
    Adv Colloid Interface Sci; 2009 Jan; 145(1-2):1-22. PubMed ID: 18774120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing productivity of chromatography steps for purification of monoclonal antibodies.
    Tugcu N; Roush DJ; Göklen KE
    Biotechnol Bioeng; 2008 Feb; 99(3):599-613. PubMed ID: 17680666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recovery and purification of monoclonal antibody producted by continuous perfusion culture using expended bed adsorption].
    Yu XL; Mi L; Yao XY; Chen ZN
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):227-32. PubMed ID: 15969113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decisional tool to assess current and future process robustness in an antibody purification facility.
    Stonier A; Simaria AS; Smith M; Farid SS
    Biotechnol Prog; 2012 Jul; 28(4):1019-28. PubMed ID: 22641562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream processing of monoclonal antibodies--application of platform approaches.
    Shukla AA; Hubbard B; Tressel T; Guhan S; Low D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):28-39. PubMed ID: 17046339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.